{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:13:49Z","timestamp":1768533229720,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hospital Universitari Son Espases Pilot Projetc Program","award":["PILOTO2024\/GADEA"],"award-info":[{"award-number":["PILOTO2024\/GADEA"]}]},{"name":"Instituto de la Salud Carlos III (ISCIII) - Miguel Servet project and European Union","award":["CP22\/00131"],"award-info":[{"award-number":["CP22\/00131"]}]},{"name":"Co-funded program for Personalized Medicine from the Institut d\u2019Investigaci\u00f3 Sanit\u00e0ria Illes Balears and Janssen Pharmaceuticals","award":["RADIX\/JANSSEN21\/01"],"award-info":[{"award-number":["RADIX\/JANSSEN21\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02735-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T02:57:47Z","timestamp":1768186667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Definitive single-fraction ablative radiotherapy for early-stage breast cancer: DESERT-I trial \u2013 a dose-escalation study protocol"],"prefix":"10.1186","volume":"21","author":[{"given":"Jon","family":"Gadea-Quinteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Gonz\u00e1lez-Alcantud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Torres-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Garc\u00eda-Zanoguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Camarasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Matheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Sans\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavi","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"2","key":"2735_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","volume":"35","author":"S Loibl","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, et al. Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35(2):159\u201382. Epub 2023 Dec 13. PMID: 38101773.","journal-title":"Ann Oncol"},{"issue":"1","key":"2735_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamaoncol.2023.4837","volume":"10","author":"JD Benitez Fuentes","year":"2024","unstructured":"Benitez Fuentes JD, Morgan E, de Luna Aguilar A, Mafra A, Shah R, Giusti F, et al. Global stage distribution of breast cancer at diagnosis: A systematic review and Meta-Analysis. JAMA Oncol. 2024;10(1):71\u20138. PMID: 37943547; PMCID: PMC10636649.","journal-title":"JAMA Oncol"},{"key":"2735_CR3","doi-asserted-by":"crossref","unstructured":"Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO Evidence-Based consensus statement. Pract Radiat Oncol. 2017 Mar-Apr;7(2):73\u20139. Epub 2016 Sep 17. PMID: 27866865.","DOI":"10.1016\/j.prro.2016.09.007"},{"issue":"10237","key":"2735_CR4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, FAST-Forward Trial Management Group, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6. Epub 2020 Apr 28. PMID: 32580883; PMCID: PMC7262592.","journal-title":"Lancet"},{"issue":"3","key":"2735_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.radonc.2013.10.033","volume":"110","author":"F van der Leij","year":"2014","unstructured":"van der Leij F, Elkhuizen PH, Janssen TM, Poortmans P, van der Sangen M, Scholten AN, et al. Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation. Radiother Oncol. 2014;110(3):467\u201370. Epub 2013 Nov 18. PMID: 24262820.","journal-title":"Radiother Oncol"},{"issue":"8","key":"2735_CR6","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.21037\/tcr-20-1833","volume":"9","author":"S Aoki","year":"2020","unstructured":"Aoki S, Yamashita H, Abe O, Nakagawa K. Stereotactic body radiotherapy (SBRT) for oligo-metastatic liver metastases from breast cancer, as an effective and safe alternative to surgery: a review. Transl Cancer Res. 2020;9(8):5087\u201395. https:\/\/doi.org\/10.21037\/tcr-20-1833. PMID: 35117874; PMCID: PMC8799143.","journal-title":"Transl Cancer Res"},{"issue":"3","key":"2735_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000528640","volume":"46","author":"A Piras","year":"2023","unstructured":"Piras A, Sanfratello A, Boldrini L, D\u2019Aviero A, Pernice G, Sortino G, et al. Stereotactic radiotherapy in Early-Stage breast cancer in neoadjuvant and exclusive settings: A systematic review. Oncol Res Treat. 2023;46(3):116\u201323. Epub 2022 Dec 12. PMID: 36509043.","journal-title":"Oncol Res Treat"},{"issue":"4","key":"2735_CR8","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","volume":"106","author":"JE Vasmel","year":"2020","unstructured":"Vasmel JE, Charaghvandi RK, Houweling AC, Philippens MEP, van Asselen B, Vreuls CPH, et al. Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation. Int J Radiat Oncol Biol Phys. 2020;106(4):821\u20139. Epub 2019 Dec 5. PMID: 31812720.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"2735_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.prro.2018.03.009","volume":"8","author":"RW Gao","year":"2018","unstructured":"Gao RW, Park SS, Jakub JW, Hieken TJ, Conners AL, Neal L, et al. Durable response of early-stage breast cancer to bilateral definitive SBRT in a medically inoperable patient. Pract Radiat Oncol. 2018;8(6):361\u20135. https:\/\/doi.org\/10.1016\/j.prro.2018.03.009.","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"2735_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.adro.2018.03.007","volume":"3","author":"JW Lischalk","year":"2018","unstructured":"Lischalk JW, Chen H, Repka MC, Campbell LD, Obayomi-Davies O, Kataria S, et al. Definitive hypofractionated radiation therapy for early stage breast cancer: dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors. Adv Radiat Oncol. 2018;3(3):447\u201357. https:\/\/doi.org\/10.1016\/j.adro.2018.03.007.","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"2735_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/s1470-2045(02)00950-4","volume":"3","author":"JS Vaidya","year":"2002","unstructured":"Vaidya JS, Hall-Craggs M, Baum M, Tobias JS, Falzon M, D\u2019Souza DP, et al. Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol. 2002;3(12):702\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(02)00950-4.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2735_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.rpor.2020.07.008","volume":"25","author":"M Veluvolu","year":"2020","unstructured":"Veluvolu M, Patel M, Narayanasamy G, Kim T. Definitive single fraction stereotactic ablative radiotherapy for inoperable early-stage breast cancer: A case report. Rep Pract Oncol Radiother. 2020;25(5):760\u20134. https:\/\/doi.org\/10.1016\/j.rpor.2020.07.008.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"4","key":"2735_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ijrobp.2015.03.007","volume":"92","author":"JK Horton","year":"2015","unstructured":"Horton JK, Blitzblau RC, Yoo S, Geradts J, Chang Z, Baker JA, et al. Preoperative Single-Fraction partial breast radiation therapy: A novel phase 1, Dose-Escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys. 2015;92(4):846\u201355. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.007.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2735_CR14","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Published: November 27, 2017. U.S. Department of Health and Human Services. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Available from: Accessed November 2024."},{"key":"2735_CR15","doi-asserted-by":"publisher","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026. PMID: 19097774.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2735_CR16","unstructured":"European Organisation for Research and Treatment of Cancer. EORTC Quality of Life Questionnaires. In: EORTC Quality of Life Group. https:\/\/qol.eortc.org\/questionnaires\/. Accessed November 2024."},{"issue":"1","key":"2735_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12885-017-3144-5","volume":"17","author":"RK Charaghvandi","year":"2017","unstructured":"Charaghvandi RK, van Asselen B, Philippens ME, Verkooijen HM, van Gils CH, van Diest PJ, Pijnappel RM, Hobbelink MG, Witkamp AJ, van Dalen T, van der Wall E, van Heijst TC, Koelemij R, van Vulpen M, van den Bongard HJ. Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol. BMC Cancer. 2017;17(1):181. https:\/\/doi.org\/10.1186\/s12885-017-3144-5. PMID: 28274211; PMCID: PMC5343419.","journal-title":"BMC Cancer"},{"key":"2735_CR18","doi-asserted-by":"publisher","unstructured":"Charaghvandi RK, den Hartogh MD, van Ommen AM, de Vries WJ, Scholten V, Moerland MA, Philippens ME, Schokker RI, van Vulpen M, van Asselen B, van den Bongard DH. MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study. Radiother Oncol. 2015;117(3):477\u201382. https:\/\/doi.org\/10.1016\/j.radonc.2015.09.023. Epub 2015 Oct 1. PMID: 26438972.","DOI":"10.1016\/j.radonc.2015.09.023"},{"key":"2735_CR19","doi-asserted-by":"crossref","unstructured":"International Commission on Radiation Units and Measurements. ICRU report 83 - Prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). J ICRU. 2010;10(1).","DOI":"10.1093\/jicru\/ndq002"},{"issue":"1","key":"2735_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12885-023-10910-6","volume":"23","author":"YA Civil","year":"2023","unstructured":"Civil YA, Oei AL, Duvivier KM, Bijker N, Meijnen P, Donkers L, et al. Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial\u2014a study protocol. BMC Cancer. 2023;23(1):419. https:\/\/doi.org\/10.1186\/s12885-023-10910-6. PMID: 37161377; PMCID: PMC10169374.","journal-title":"BMC Cancer"},{"issue":"10","key":"2735_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jnci\/djp079","volume":"101","author":"C Le Tourneau","year":"2009","unstructured":"Le Tourneau C, Lee JJ, Siu LL. Dose escalation methods in phase I cancer clinical trials. J Natl Cancer Inst. 2009;101(10):708\u201320. https:\/\/doi.org\/10.1093\/jnci\/djp079. Epub 2009 May 12. PMID: 19436029; PMCID: PMC2684552.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2735_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/00000658-197205000-00002","volume":"175","author":"JL Madden","year":"1972","unstructured":"Madden JL, Kandalaft S, Bourque RA. Modified radical mastectomy. Ann Surg. 1972;175(5):624\u201334. https:\/\/doi.org\/10.1097\/00000658-197205000-00002. PMID: 4555029; PMCID: PMC1355229.","journal-title":"Ann Surg"},{"key":"2735_CR23","doi-asserted-by":"publisher","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546\u201353. https:\/\/doi.org\/10.1056\/NEJMoa012782. PMID: 12904519.","DOI":"10.1056\/NEJMoa012782"},{"issue":"6","key":"2735_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M. Axillary dissection vs no axillary dissection in women with invasive breast cancer and Sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u201375. https:\/\/doi.org\/10.1001\/jama.2011.90. PMID: 21304082; PMCID: PMC5389857.","journal-title":"JAMA"},{"key":"2735_CR25","doi-asserted-by":"publisher","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750-69. https:\/\/doi.org\/10.1016\/S0140-6736(20)32381-3. Epub 2021 Apr 1. Erratum in: Lancet. 2021;397(10286):1710. https:\/\/doi.org\/10.1016\/S0140-6736(21)00838-2. PMID: 33812473.","DOI":"10.1016\/S0140-6736(20)32381-3"},{"key":"2735_CR26","doi-asserted-by":"publisher","unstructured":"Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA, American Society for Therapeutic Radiology and Oncology; American College of Radiology. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76(2):326\u201332. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.042. PMID: 20117285.","DOI":"10.1016\/j.ijrobp.2009.09.042"},{"issue":"2","key":"2735_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","volume":"88","author":"JM Brown","year":"2014","unstructured":"Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys. 2014;88(2):254\u201362. PMID: 24411596; PMCID: PMC3893711.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2735_CR28","doi-asserted-by":"publisher","unstructured":"Loo BW Jr, Chang JY, Dawson LA, Kavanagh BD, Koong AC, Senan S, Timmerman RD. Stereotactic ablative radiotherapy: what\u2019s in a name? Pract Radiat Oncol. 2011 Jan-Mar;1(1):38\u20139. https:\/\/doi.org\/10.1016\/j.prro.2010.07.001. Epub 2011 Jan 14. PMID: 24673868.","DOI":"10.1016\/j.prro.2010.07.001"},{"key":"2735_CR29","doi-asserted-by":"publisher","unstructured":"Bondiau PY, Courdi A, Bahadoran P, Chamorey E, Queille-Roussel C, Lallement M, Birtwisle-Peyrottes I, Chapellier C, Pacquelet-Cheli S, Ferrero JM. Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2013;85(5):1193-9. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.10.034. Epub 2013 Jan 16. PMID: 23332384.","DOI":"10.1016\/j.ijrobp.2012.10.034"},{"issue":"3","key":"2735_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ijrobp.2024.07.2326","volume":"121","author":"YA Civil","year":"2025","unstructured":"Civil YA, Vasmel JE, Charaghvandi RK, Houweling AC, Vreuls CPH, van Diest PJ, Witkamp AJ, Doeksen A, van Dalen T, Felderhof J, van Dam I, Slotman BJ, Kirby AM, Verkooijen HM, van der Velde S, van der Leij F, van den Bongard HJGD. Preoperative magnetic resonance guided Single-Dose partial breast irradiation: 5-Year results of the prospective Single-Arm ABLATIVE trial. Int J Radiat Oncol Biol Phys. 2025;121(3):613\u201322. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.07.2326. Epub 2024 Aug 2. PMID: 39098432.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2735_CR31","doi-asserted-by":"publisher","first-page":"110510","DOI":"10.1016\/j.radonc.2024.110510","volume":"200","author":"D Mahmoud","year":"2024","unstructured":"Mahmoud D, Yassa M, Alvarado L, Lambert C, Meterissian S, Anderson D, et al. Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: early results of a phase 2 study. Radiother Oncol. 2024;200:110510. https:\/\/doi.org\/10.1016\/j.radonc.2024.110510. Epub 2024 Aug 30. PMID: 39218040.","journal-title":"Radiother Oncol"},{"key":"2735_CR32","doi-asserted-by":"publisher","first-page":"110515","DOI":"10.1016\/j.radonc.2024.110515","volume":"200","author":"D Lavigne","year":"2024","unstructured":"Lavigne D, Hijal T, Vavassis P, Guilbert MC, Sideris L, Dub\u00e9 P, et al. Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial. Radiother Oncol. 2024;200:110515. Epub 2024 Aug 30. PMID: 39218041.","journal-title":"Radiother Oncol"},{"key":"2735_CR33","doi-asserted-by":"crossref","unstructured":"Moore-Palhares D, Chen H, Khan BM, McCann C, Bosnic S, Hahn E, et al. Locoregional ablative radiation therapy for patients with breast cancer unsuitable for surgical resection. Pract Radiat Oncol. 2024 Jul-Aug;14(4):316\u201327. Epub 2023 Dec 26. PMID: 38154688.","DOI":"10.1016\/j.prro.2023.12.003"},{"issue":"17","key":"2735_CR34","doi-asserted-by":"publisher","first-page":"15553","DOI":"10.1007\/s00432-023-05053-x","volume":"149","author":"M Miljanic","year":"2023","unstructured":"Miljanic M, Nwachukwu C, Rahimi A. Definitive ablative stereotactic partial breast irradiation in early-stage inoperable breast cancer. J Cancer Res Clin Oncol. 2023;149(17):15553\u20139. https:\/\/doi.org\/10.1007\/s00432-023-05053-x. Epub 2023 Aug 31. PMID: 37648809.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2735_CR35","unstructured":"Clinicaltrials.gov. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03585621. Accessed November 2024."},{"issue":"4","key":"2735_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105(4):256\u201365. https:\/\/doi.org\/10.1093\/jnci\/djs629. Epub 2013 Jan 4. PMID: 23291374; PMCID: PMC3576324.","journal-title":"J Natl Cancer Inst"},{"key":"2735_CR37","doi-asserted-by":"publisher","unstructured":"Garcia-Murillas I, Chopra N, Comino-M\u00e9ndez I, Beaney M, Tovey H, Cutts RJ, et al. Assessment of molecular relapse detection in early-stage breast cancer. JAMA Oncol. 2019;5(10):1473-8. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1838. Erratum in: JAMA Oncol. 2020;6(1):162. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6325. PMID: 31369045; PMCID: PMC6681568.","DOI":"10.1001\/jamaoncol.2019.1838"},{"key":"2735_CR38","doi-asserted-by":"publisher","unstructured":"Burnette B, Weichselbaum RR. Radiation as an immune modulator. Semin Radiat Oncol. 2013;23(4):273\u201380. https:\/\/doi.org\/10.1016\/j.semradonc.2013.05.009. PMID: 24012341.","DOI":"10.1016\/j.semradonc.2013.05.009"},{"issue":"14","key":"2735_CR39","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.18.02157","volume":"37","author":"A Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs A, Stenmark Tullberg A, Werner R\u00f6nnerman E, Holmberg E, Hartman L, Sj\u00f6str\u00f6m M, et al. Effect of radiotherapy after breast-conserving surgery depending on the presence of tumor-infiltrating lymphocytes: a long-term follow-up of the SweBCG91RT randomized trial. J Clin Oncol. 2019;37(14):1179\u201387. https:\/\/doi.org\/10.1200\/JCO.18.02157. Epub 2019 Apr 2. PMID: 30939091.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2735_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1349-7006.2011.01940.x","volume":"102","author":"K Yasuda","year":"2011","unstructured":"Yasuda K, Nirei T, Tsuno NH, Nagawa H, Kitayama J. Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer. Cancer Sci. 2011;102(7):1257\u201363. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01940.x. Epub 2011 Apr 27. PMID: 21443690.","journal-title":"Cancer Sci"},{"issue":"24","key":"2735_CR41","first-page":"6028","volume":"59","author":"PK Chakravarty","year":"1999","unstructured":"Chakravarty PK, Alfieri A, Thomas EK, Beri V, Tanaka KE, Vikram B, et al. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res. 1999;59(24):6028\u201332. PMID: 10626784.","journal-title":"Cancer Res"},{"key":"2735_CR42","doi-asserted-by":"publisher","unstructured":"Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004;58(3):862\u201370. https:\/\/doi.org\/10.1016\/j.ijrobp.2003.09.012. PMID: 14967443.","DOI":"10.1016\/j.ijrobp.2003.09.012"},{"issue":"24","key":"2735_CR43","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1158\/1078-0432.CCR-12-0984","volume":"18","author":"MZ Dewan","year":"2012","unstructured":"Dewan MZ, Vanpouille-Box C, Kawashima N, DiNapoli S, Babb JS, Formenti SC, et al. Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer. Clin Cancer Res. 2012;18(24):6668\u201378. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0984. Epub 2012 Oct 9. PMID: 23048078; PMCID: PMC3525760.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2735_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12609-017-0234-y","volume":"9","author":"ZI Hu","year":"2017","unstructured":"Hu ZI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer? Curr Breast Cancer Rep. 2017;9(1):45\u201351. https:\/\/doi.org\/10.1007\/s12609-017-0234-y. Epub 2017 Mar 2. PMID: 28344743; PMCID: PMC5346418.","journal-title":"Curr Breast Cancer Rep"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02735-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:41:35Z","timestamp":1768473695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02735-3","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was designed in compliance with the principles of the Declaration of Helsinki and adheres to Good Clinical Practice (GCP) guidelines. The study protocol was approved by the Research Committee of the Son Espases University Hospital in Palma de Mallorca, Spain. It subsequently received a favorable report from the Research Ethics Committee of the Balearic Islands (IB 5560\/24 PI). Before enrollment, all patients are required to provide written informed consent after a thorough and detailed explanation of the study procedures. The trial has been registered on clinicaltrials.gov (NCT06671691).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from a participant for the publication of the simulation CT images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}